Use of the xCELLigence System for Quantification of Bacterial Biofilm's Real Time Formation and Antibiotics Selection.

University of Valencia

Status and phase: Unknown; Phase 4

Conditions: Resistance Bacterial; Chronic Periodontitis; Periodontal Bone Loss

Treatments: Diagnostic Test: MICROBIAL SAMPLING; Drug: ADJUNTIVE ANTIBIOTICS; Procedure: SCALE AND ROOT PLANING

Study type: Interventional

Funder types: Other

Identifiers

NCT03863249

UV4

Details and patient eligibility

About

The aim of the study is to develop an in vitro model of growth of oral biofilms, and validate xCELLigence system for the selection of an effective antibiotic treatment for each patient.

Full description

Periodontitis in a chronic disease caused by bacteria present in the subgingival flora, which induces an inflammatory response of periodontal tissues. It has been suggested that some periodontal pathogens may be inaccessible to mechanical periodontal therapy due to its ability to invade the gingival tissues and evade defense mechanisms of the host. Therefore, it is conceivable that coadjuvant administration of antimicrobials may improve the outcome of mechanical therapy. There are several techniques to monitor periodontal pathogens and determine antibiotic therapy. But the most important disadvantage of conventional laboratory methods is that they are indirect, based on the molecular detection of 3 to 10 bacterial species, without analyzing whether the biofilm as a whole is sensitive or resistant to treatment, being a possible cause of failure and / or recurrence of the disease, in addition to the risk of development of antimicrobial resistance.

The investigators hypothesis is that the specific selection of antimicrobial treatment with the xCELLigence system allows better improvements in clinical parameters than indirect laboratory methods.

Materials and methods:

A randomized double-blind clinical trial will be launched. Samples of subgingival plaque will be taken with paper tips. Subjects included in the study will be randomized to one of 3 treatment groups: scaling and root planing combined with systemically administration of antibiotic suggested by the xCELLigence system; scaling and root planing combined with systemically administration of antibiotic suggested by 'Echevarne' laboratory and scaling and root planing combined with systemically administration of antibiotic suggested by 'Origen' laboratory.

Enrollment: 60 estimated patients

Sex: All

Ages: 40 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Subjects of 40-70 years.
2. No smokers or smokers of less than 10 cigarettes a day.
3. Patients with periodontitis stages III and IV grades A-B.
4. Presence of 20 natural teeth, including at least three molar teeth.
5. Presence of at least 4 sites with at least 6 mm probing depth.
6. Good general health

Exclusion criteria

1. Smokers of more than 10 cigarettes a day.
2. Patients who have received periodontal treatment in the previous 12 months.
3. Patients who have used antibiotics in the last 6 months.
4. Routine use of oral antiseptics and / or during the previous 3 months.
5. Systemic conditions that required antibiotic premedication.
6. Women pregnant or nursing.
7. Medications that could influence the outcome of periodontal therapy.
8. Any known allergies to the test antimicrobial agents.
9. Diabetics.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

60 participants in 3 patient groups

The exCELLigence system

Active Comparator group

Description:

1. Following the baseline examination each of the 20 randomly selected patients will be informed about the cause of periodontal disease. 2. The 10 deepest interproximal sites in each quadrant will be selected and exposed to microbial sampling. Two sterilized paper points will be inserted into the pocket of each site and will be keep in place for 60 s. The twin paper points will be remove and distributed in two vials and transfer for microbiological processing. 3. The study participants will undergo SCALE AND ROOT PLANING (SRP). SRP will be performed two quadrants at a time under local anaesthesia at approximately weekly intervals. 4. The adjunctive antibiotics selected by 'the exCELLingence' system will be started at the second SRP visit.

Treatment:

Diagnostic Test: MICROBIAL SAMPLING

Drug: ADJUNTIVE ANTIBIOTICS

Procedure: SCALE AND ROOT PLANING

Origen

Active Comparator group

Description:

1. Following the baseline examination each of the 20 randomly selected patients will be informed about the cause of periodontal disease. 2. The 10 deepest interproximal sites in each quadrant will be selected and exposed to microbial sampling. Two sterilized paper points will be inserted into the pocket of each site and will be keep in place for 60 s. The twin paper points will be remove and distributed in two vials and transfer for microbiological processing. 3. The study participants will undergo SCALE AND ROOT PLANING (SRP). SRP will be performed two quadrants at a time under local anaesthesia at approximately weekly intervals. 4. The adjunctive antibiotics agents selected by 'Origen' laboratories analysis will be started at the second SRP visit.

Treatment:

Diagnostic Test: MICROBIAL SAMPLING

Drug: ADJUNTIVE ANTIBIOTICS

Procedure: SCALE AND ROOT PLANING

Echevarne

Active Comparator group

Description:

1. Following the baseline examination each of the 20 randomly selected patients will be informed about the cause of periodontal disease. 2. The 10 deepest interproximal sites in each quadrant will be selected and exposed to microbial sampling. Two sterilized paper points will be inserted into the pocket of each site and will be keep in place for 60 s. The twin paper points will be remove and distributed in two vials and transfer for microbiological processing. 3. The study participants will undergo SCALE AND ROOT PLANING (SRP). SRP will be performed two quadrants at a time under local anaesthesia at approximately weekly intervals. 4. The adjunctive antibiotics agents selected by 'Echevarne' laboratories analysis will be started at the second SRP visit.

Treatment:

Diagnostic Test: MICROBIAL SAMPLING

Drug: ADJUNTIVE ANTIBIOTICS

Procedure: SCALE AND ROOT PLANING